Editas Medicine, Inc. — Director's Dealing 2016

Feb 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-02-03

Reporting Person: Bosley Katrine (Director, President and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-03	Stock Option (right to buy)	$16	A	38461	Acquired	2026-02-02	Common Stock (38461)	Direct

Footnotes

F1: This option was granted on February 3, 2016 and is scheduled to vest over four years with one quarter of the shares scheduled to vest on February 2, 2017, and the remaining shares scheduled to vest in equal monthly installments of 1/48th of the shares thereafter through February 2, 2020.